SGLT2 inhibitors (Sodium-Glucose Cotransporter-2 inhibitors) are a class of drugs primarily used to treat type 2 diabetes mellitus, heart failure, and chronic kidney disease (CKD). They lower blood glucose by blocking glucose reabsorption in the kidneys, causing excess glucose to be excreted in the urine. The following is a list of APIs used as SGLT2 inhibitors.
Filters
Modal title
Thank you
Thank you for sending us request for the quotation. We will get back to you asap. Thank you
Thank you
Thank you for contacting us. We will get back to you asap. Thank you
Thank you
Thank you for request submission to join as consultant. We will get back to you asap. Thank you
Thank you
Thank you for request submission to become a supplier. We will get back to you asap. Thank you
Thank you
Thank you for enquiry. We will get back to you asap. Thank you
